CNN CNN Newsroom With Pamela Brown October 16, 2021 22:54:00
You know, i always thought this was a two-dose vaccine all along. i know the company had hoped that it could serve as a one-dose vaccine from the simple standpoint that globally, you know, it could go much faster and spread among -- and be delivered to many more people globally. so i think their intentions were good. and they actually finally came -- had phase-three trial data for the two doses in september. and it was pretty stunning. it's over 90% protection. so i wish it was messaged a little differently. you know, what i've been saying since the beginning, since january, is that the two mr...